Dominant Gene Mutation Causes Incurable Eye Disorder
By LabMedica International staff writers Posted on 02 Feb 2015 |
Retinitis pigmentosa damages the retina and its early symptoms include decreased night vision and peripheral vision and once it starts, the loss of vision is relentlessly progressive, often ending in blindness.
Retinitis pigmentosa (RP) is exceptionally heterogeneous with many different genes implicated, many different disease-causing mutations in each gene, and varying clinical presentations even among members of the same family.
A team of scientists led by those at the University of Texas Health Science Center (Houston, TX, USA) carried out exhaustive hereditary analysis of a large family with vision issues, and has uncovered a new gene tied to an incurable eye disorder called retinitis pigmentosa. The patient cohort contains 265 families with a high likelihood of autosomal dominant inheritance. One affected individual from each family has been tested previously for mutations in the currently known autosomal dominant RP (ad RP) genes.
Genomic DNAs from nine affected, six unaffected at-risk, and one unaffected member of the affected family were genotyped with an ABI High Density 5cM 100 STR marker set (Life Technologies; Grand Island, NY, USA). Exome sequencing and the hexokinase 1 (HK1) exome variant was typed by amplification and fluorescent di-deoxy sequencing with polymerase chain reaction (PCR) primers. The team also performed a Glucose 6 Phosphate (G6P) assay in affected individuals and colorimetric measurements were made using optical density (OD) 450 nm measurements on an Epoch microplate spectrophotometer (BioTek; Winooski, VT, USA).
Exome sequencing in the affected family led to identification of a single, novel coding variant33 (c.2539G>A, p.Glu847Lys) in the hexokinase 1 gene (HK1) present in all affected individuals and absent from normal controls. One affected family member carries two copies of the mutation and has an unusually severe form of disease, consistent with homozygosity for this mutation. Screening of additional adRP probands identified four other families (American, Canadian, and Sicilian) with the same mutation and a similar range of phenotypes. The families share a rare 450 kilobase haplotype containing the mutation, suggesting a founder mutation among otherwise unrelated families.
Stephen P. Daiger, PhD, the senior author of the study, said, “The story of the HK1 mutation is itself interesting. What we found is a mutation present in families from Louisiana, Canada, and Sicily. Our evidence suggests the mutation arose in a common ancestor who lived centuries ago. The mutation spread in Europe and North America, and may be common among Acadians in Louisiana. This is called a founder mutation.” The team hypothesized that the effect of this mutation is limited to the retina, as no systemic abnormalities in glycolysis were detected. The study was first published on September 4, 2014, in the journal Ophthalmology & Visual Science.
Related Links:
University of Texas Health Science Center
Life Technologies
BioTek
Retinitis pigmentosa (RP) is exceptionally heterogeneous with many different genes implicated, many different disease-causing mutations in each gene, and varying clinical presentations even among members of the same family.
A team of scientists led by those at the University of Texas Health Science Center (Houston, TX, USA) carried out exhaustive hereditary analysis of a large family with vision issues, and has uncovered a new gene tied to an incurable eye disorder called retinitis pigmentosa. The patient cohort contains 265 families with a high likelihood of autosomal dominant inheritance. One affected individual from each family has been tested previously for mutations in the currently known autosomal dominant RP (ad RP) genes.
Genomic DNAs from nine affected, six unaffected at-risk, and one unaffected member of the affected family were genotyped with an ABI High Density 5cM 100 STR marker set (Life Technologies; Grand Island, NY, USA). Exome sequencing and the hexokinase 1 (HK1) exome variant was typed by amplification and fluorescent di-deoxy sequencing with polymerase chain reaction (PCR) primers. The team also performed a Glucose 6 Phosphate (G6P) assay in affected individuals and colorimetric measurements were made using optical density (OD) 450 nm measurements on an Epoch microplate spectrophotometer (BioTek; Winooski, VT, USA).
Exome sequencing in the affected family led to identification of a single, novel coding variant33 (c.2539G>A, p.Glu847Lys) in the hexokinase 1 gene (HK1) present in all affected individuals and absent from normal controls. One affected family member carries two copies of the mutation and has an unusually severe form of disease, consistent with homozygosity for this mutation. Screening of additional adRP probands identified four other families (American, Canadian, and Sicilian) with the same mutation and a similar range of phenotypes. The families share a rare 450 kilobase haplotype containing the mutation, suggesting a founder mutation among otherwise unrelated families.
Stephen P. Daiger, PhD, the senior author of the study, said, “The story of the HK1 mutation is itself interesting. What we found is a mutation present in families from Louisiana, Canada, and Sicily. Our evidence suggests the mutation arose in a common ancestor who lived centuries ago. The mutation spread in Europe and North America, and may be common among Acadians in Louisiana. This is called a founder mutation.” The team hypothesized that the effect of this mutation is limited to the retina, as no systemic abnormalities in glycolysis were detected. The study was first published on September 4, 2014, in the journal Ophthalmology & Visual Science.
Related Links:
University of Texas Health Science Center
Life Technologies
BioTek
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Molecular Diagnostics News
- World’s First One-Minute Hepatitis C Antibody Test Facilitates Quick Triage
- Game-Changing Blood Test for Stroke Detection Could Bring Life-Saving Care to Patients
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis